{"id":"https://openalex.org/W4390915377","doi":"https://doi.org/10.1158/1538-7445.panca2023-a059","title":"Abstract A059: Targeting pancreatic cancer metabolic dependencies through glutamine antagonism","display_name":"Abstract A059: Targeting pancreatic cancer metabolic dependencies through glutamine antagonism","publication_year":2024,"publication_date":"2024-01-16","ids":{"openalex":"https://openalex.org/W4390915377","doi":"https://doi.org/10.1158/1538-7445.panca2023-a059"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.panca2023-a059","doi":"https://doi.org/10.1158/1538-7445.panca2023-a059","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.panca2023-a059","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5066604945","display_name":"Joel Encarnaci\u00f3n-Rosado","orcid":"https://orcid.org/0000-0002-0440-4278","observed_orcids":["https://orcid.org/0000-0002-0440-4278"]},"institutions":[{"id":"https://openalex.org/I4210086933","display_name":"NYU Langone Health","ror":"https://ror.org/005dvqh91","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210086933"]},{"id":"https://openalex.org/I57206974","display_name":"New York University","ror":"https://ror.org/0190ak572","country_code":"US","type":"education","lineage":["https://openalex.org/I57206974"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joel Encarnacion-Rosado","raw_affiliation_strings":["1NYU School of Medicine, New York, NY,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1NYU School of Medicine, New York, NY,","institution_ids":["https://openalex.org/I4210086933","https://openalex.org/I57206974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011348783","display_name":"Alec C. Kimmelman","orcid":"https://orcid.org/0009-0002-9465-8411","observed_orcids":["https://orcid.org/0009-0002-9465-8411"]},"institutions":[{"id":"https://openalex.org/I4210086933","display_name":"NYU Langone Health","ror":"https://ror.org/005dvqh91","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210086933"]},{"id":"https://openalex.org/I57206974","display_name":"New York University","ror":"https://ror.org/0190ak572","country_code":"US","type":"education","lineage":["https://openalex.org/I57206974"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alec C. Kimmelman","raw_affiliation_strings":["1NYU School of Medicine, New York, NY,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1NYU School of Medicine, New York, NY,","institution_ids":["https://openalex.org/I4210086933","https://openalex.org/I57206974"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5114832305","display_name":"Robert Wild","orcid":"https://orcid.org/0000-0001-9182-3587","observed_orcids":["https://orcid.org/0000-0001-9182-3587"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert Wild","raw_affiliation_strings":["2Dracen Pharmaceuticals, Inc., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Dracen Pharmaceuticals, Inc., San Diego, CA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"84","issue":"2_Supplement","first_page":"A059","last_page":"A059"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10631","display_name":"Cancer, Hypoxia, and Metabolism","score":0.5698000192642212,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10631","display_name":"Cancer, Hypoxia, and Metabolism","score":0.5698000192642212,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.36010000109672546,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12770","display_name":"Amino Acid Enzymes and Metabolism","score":0.022099999710917473,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pancreatic-ductal-adenocarcinoma","display_name":"pancreatic ductal adenocarcinoma","score":0.9990000128746033},{"id":"https://openalex.org/keywords/glutamine-metabolism","display_name":"glutamine metabolism","score":0.9160000085830688},{"id":"https://openalex.org/keywords/6-diazo-5-oxo-l-norleucine","display_name":"6-diazo-5-oxo-L-norleucine","score":0.9490000009536743},{"id":"https://openalex.org/keywords/glutaminase-inhibitors","display_name":"glutaminase inhibitors","score":0.6729999780654907},{"id":"https://openalex.org/keywords/metabolic-reprogramming","display_name":"metabolic reprogramming","score":0.7990000247955322},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.8410000205039978},{"id":"https://openalex.org/keywords/desmoplasia","display_name":"desmoplasia","score":0.9240000247955322},{"id":"https://openalex.org/keywords/hypoxia","display_name":"hypoxia","score":0.7269999980926514},{"id":"https://openalex.org/keywords/erk-signaling","display_name":"ERK signaling","score":0.9440000057220459},{"id":"https://openalex.org/keywords/receptor-tyrosine-kinases","display_name":"receptor tyrosine kinase","score":0.9139999747276306},{"id":"https://openalex.org/keywords/trametinib","display_name":"trametinib","score":0.8970000147819519},{"id":"https://openalex.org/keywords/mek-inhibitors","display_name":"MEK inhibitors","score":0.7139999866485596},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7929999828338623},{"id":"https://openalex.org/keywords/tumor-growth","display_name":"tumor growth","score":0.5040000081062317}],"concepts":[{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6309647560119629},{"id":"https://openalex.org/C2780210213","wikidata":"https://www.wikidata.org/wiki/Q212961","display_name":"Pancreatic cancer","level":3,"score":0.5647308230400085},{"id":"https://openalex.org/C2779349466","wikidata":"https://www.wikidata.org/wiki/Q181619","display_name":"Glutamine","level":3,"score":0.553595781326294},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.5467690825462341},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5362659692764282},{"id":"https://openalex.org/C101544691","wikidata":"https://www.wikidata.org/wiki/Q420511","display_name":"Receptor tyrosine kinase","level":3,"score":0.5134400129318237},{"id":"https://openalex.org/C2778160063","wikidata":"https://www.wikidata.org/wiki/Q1532402","display_name":"Glutaminolysis","level":4,"score":0.4716704785823822},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4661693871021271},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.4244781732559204},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.41477590799331665},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.33760905265808105},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3278542757034302},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.1647821068763733},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.14328154921531677},{"id":"https://openalex.org/C3020616263","wikidata":"https://www.wikidata.org/wiki/Q1216998","display_name":"Tumor cells","level":2,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C515207424","wikidata":"https://www.wikidata.org/wiki/Q8066","display_name":"Amino acid","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.panca2023-a059","doi":"https://doi.org/10.1158/1538-7445.panca2023-a059","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.panca2023-a059","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4387451329","https://openalex.org/W3098422646","https://openalex.org/W4387451269","https://openalex.org/W2741653872","https://openalex.org/W3030858653","https://openalex.org/W4412137529","https://openalex.org/W4390013944","https://openalex.org/W2910547814","https://openalex.org/W3168097011","https://openalex.org/W4403057632"],"abstract_inverted_index":{"Abstract":[0],"Pancreatic":[1,303],"ductal":[2],"adenocarcinoma":[3],"(PDAC)":[4],"is":[5,24,33,205],"one":[6],"of":[7,11,21,35,136,179,195,215,222,295],"the":[8,18,22,25,192,212,261,272,296],"deadliest":[9],"types":[10],"cancer.":[12],"A":[13],"factor":[14],"that":[15,71,102,147,181,202,246,260],"contributes":[16],"to":[17,76,85,125,184,229],"poor":[19],"prognosis":[20],"disease":[23],"complex":[26],"tumor":[27,161],"microenvironment":[28],"(TME).":[29],"The":[30],"PDAC":[31,60,72,116,130,258],"TME":[32],"composed":[34],"excessive":[36],"fibrosis":[37],"and":[38,48,55,79,97,117,132,143,170,190,224,259],"desmoplasia,":[39],"which":[40],"creates":[41,149],"a":[42,103,126,133,150,157,175,208,230,236,253],"harsh":[43],"environment":[44],"resulting":[45],"in":[46,57,93,115,129,140,160,163,165,233,235,300],"hypoxia":[47],"altered":[49],"nutrient":[50],"availability.":[51],"To":[52],"promote":[53],"survival":[54,234],"proliferation":[56,78,131],"this":[58],"environment,":[59],"cells":[61,73],"can":[62],"reprogram":[63],"glutamine":[64,290],"(Gln)":[65],"metabolism.":[66],"Previous":[67],"studies":[68],"have":[69],"demonstrated":[70],"use":[74],"Gln":[75,87,104,113,197,249],"support":[77],"redox":[80],"balance.":[81],"However,":[82],"earlier":[83],"attempts":[84],"inhibit":[86],"metabolism":[88,114,250],"using":[89,172],"glutaminase":[90],"inhibitors":[91],"resulted":[92],"rapid":[94,119],"metabolic":[95,151,287],"reprogramming":[96],"therapeutic":[98,193,255,273],"resistance.":[99],"We":[100],"hypothesized":[101],"analogue,":[105],"such":[106],"as":[107,207],"6-Diazo-5-oxo-L-norleucine":[108],"(DON),":[109],"could":[110,251,269],"broadly":[111,247],"target":[112],"prevent":[118],"adaptation.":[120],"Indeed,":[121],"DON":[122,148,180,186],"treatment":[123,221],"led":[124,228],"significant":[127,158,231],"decrease":[128,159],"profound":[134],"reduction":[135],"various":[137,164],"metabolites":[138],"involved":[139],"central":[141],"carbon":[142],"nucleotide":[144],"metabolism,":[145],"suggesting":[146],"crisis.":[152],"In":[153],"addition,":[154],"we":[155,200],"observed":[156],"growth":[162],"vivo":[166],"models":[167],"(syngeneic,":[168],"immunodeficient":[169],"PDXs)":[171],"DRP-104":[173,223],"(sirpiglenastat),":[174],"novel":[176],"pro-drug":[177],"version":[178],"was":[182],"designed":[183],"circumvent":[185],"associated":[187],"GI":[188],"toxicity":[189],"allow":[191],"exploration":[194],"broad":[196],"antagonism.":[198],"Mechanistically,":[199],"found":[201],"ERK":[203,265],"signaling":[204,266],"increased":[206,213],"compensatory":[209],"mechanism":[210],"through":[211,289],"activity":[214],"receptor":[216],"tyrosine":[217],"kinases":[218],"(RTKs).":[219],"Combinatorial":[220],"Trametinib":[225],"(MEK1/2)":[226],"inhibitor":[227,268],"increase":[232],"syngeneic":[237],"model":[238],"PDAC.":[239],"Taken":[240],"together,":[241],"these":[242],"pre-clinical":[243],"results":[244],"suggest":[245],"targeting":[248],"provide":[252],"new":[254],"avenue":[256],"for":[257],"combination":[262],"with":[263],"an":[264],"pathway":[267],"further":[270],"improve":[271],"outcome.":[274],"Citation":[275],"Format:":[276],"Joel":[277],"Encarnacion-Rosado,":[278],"Alec":[279],"C.":[280],"Kimmelman,":[281],"Robert":[282],"Wild.":[283],"Targeting":[284],"pancreatic":[285],"cancer":[286],"dependencies":[288],"antagonism":[291],"[abstract].":[292],"In:":[293],"Proceedings":[294],"AACR":[297],"Special":[298],"Conference":[299],"Cancer":[301,313],"Research:":[302],"Cancer;":[304],"2023":[305],"Sep":[306],"27-30;":[307],"Boston,":[308],"Massachusetts.":[309],"Philadelphia":[310],"(PA):":[311],"AACR;":[312],"Res":[314],"2024;84(2":[315],"Suppl):Abstract":[316],"nr":[317],"A059.":[318]},"counts_by_year":[{"year":2025,"cited_by_count":1}],"updated_date":"2026-10-02T10:15:12.560889","created_date":"2024-01-17T00:00:00"}